Andere talen Avecho Biotechnology Limited

Aandelen

AVE

AU0000047441

Beurs gesloten - Australian S.E. Andere beurzen 08:10:52 18-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,005 ^AUD	+25,00%		+25,00%	+42,86%

14/03	Avecho gaat door met fase III proef van anti-slapeloosheidsmedicijn	MT
07/03	Avecho Biotechnology Beveiligt Ethische Goedkeuring voor Fase Drie Slapeloosheidstest	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial	25/03
Avecho to Push Forward with Phase III Trial of Anti-Insomnia Drug	14/03
Avecho Biotechnology Secures Ethics Clearance for Phase Three Insomnia Trial	07/03
Avecho Biotechnology Limited Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Avecho Biotechnology Limited Reports Earnings Results for the Half Year Ended June 30, 2023	31-08-23
Avecho Biotechnology Achieves Two-Year Stability Milestone for CBD Capsule	22-06-23
US Patent Office Allows Avecho Biotechnology's Patent on 'Optimized' Manufacturing Method for Tocopheryl Phosphate Mixture	29-05-23
Avecho Biotechnology Signs Licensing Deal with Arthur Group for Development of Cancer Drugs	22-05-23
Avecho Biotechnology Begins Manufacturing for Oral Cannabidiol Capsules	17-05-23
Avecho Biotechnology Raises AU$2 Million Via Entitlement Offer; Shares Slip 20%	09-05-23
Avecho Biotechnology CEO optimistic about phase III insomnia CBD trial	04-04-23
Avecho Biotechnology Conducts Entitlement Offer to Raise $11 Million to Fund Pivotal Phase Iii Clinical Trial	03-04-23
Avecho Biotechnology Limited Auditor Raises 'Going Concern' Doubt	15-03-23
Avecho Biotechnology Limited Reports Earnings Results for the Full Year Ended December 31, 2022	27-02-23
Avecho Biotechnology Expands Research Partnership for Cannabidiol Medication	22-02-23
Avecho Biotechnology Limited Announces Ongoing Collaboration with Lambert Initiative	21-02-23
Athenex Pharmaceutical Division Submits Avecho's Vitamin K Injection to US FDA	12-01-23
Athenex Submits Avecho's Phytonadione to FDA Pre-IND	12-01-23
Avecho Biotechnology Secures Ethics Approval for Phase 3 Insomnia Trial	22-12-22
Avecho Biotechnology Limited Receives Ethics Approval for its Pivotal Phase III Clinical Trial Testing its Oral CBD Softgel Capsule for Insomnia	21-12-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Avecho Biotechnology Limited

Aandelen

AVE

AU0000047441

Andere talen

Filters